# General Safety and Performance Requirements (GSPR) Checklist
## According to MDR Annex XV, Section 2.7

---

## Device Information

### Investigational Device Details

| Field | Information |
|-------|-------------|
| **Device Name** | Simject (Auto-Injector) |
| **Adult Model** | SM100-005 |
| **Pediatric Model** | SM100-006 |
| **Device Type** | Single-dose, disposable, injection system with automated functions |
| **Intended Use** | Emergency treatment of severe allergic reactions (anaphylaxis) by delivering epinephrine |

### Product Description

The Simject Auto-Injector is designed to be used with liquid formulation in prefilled syringes (PFS) with different dosages but the same volume for adult and pediatric patients. Two model variants are available:

- **Adult Model (SM100-005)**: Designed for adult patients
- **Pediatric Model (SM100-006)**: Designed for pediatric patients

### Device Specifications

| Specification | Adult Model (SM100-005) | Pediatric Model (SM100-006) |
|---------------|------------------------|----------------------------|
| **Needle Extension** | 0.6 in (15.24 mm) | 0.5 in (12.70 mm) |
| **Minimum Needle Length** | ≥ 0.5 in (12.70 mm) | ≥ 0.4 in (10.16 mm) |
| **Dose** | 0.27-0.34 mg epinephrine | 0.15-0.17 mg epinephrine |

### Manufacturer Information

| Field | Information |
|-------|-------------|
| **Manufacturer** | Summed Medtech Co., Ltd. |
| **Manufacturing Address** | 5th Floor, Building 8, No. 313 Lingxiu Road, Luoxing Sub-district, Jiashan County, Jiaxing City, Zhejiang Province (314100), China |
| **Device Constitution** | Plastic and stainless steel components with spring-loaded mechanism |
| **Assembly** | Auto-injector assembled with all components (Front Component & Rear Component) except for the PFS |
| **Classification** | Device constituent of an intended final combination product |

### Supply Chain Information

**Device Provision**: The injectors are provided to pharmaceutical manufacturer **LBE Pharma Tech. Co., Ltd.**, who pre-fills the PFS with drug and assembles the injector.

**Final Product**: The Simject is not a finished device but a component of a combination product (medical device + medicinal product).

---

## Part A: Standards, Common Specifications, and Scientific Advice

### A.1 Harmonised Standards and Common Specifications

Compliance information according to Article 106 MDR (with the exception of clinical requirements assessed during clinical investigation).

| Standard/Regulation | Version/Year | Full Compliance | Partial Compliance | Deviations & Alternative Solutions |
|---------------------|--------------|-----------------|-------------------|-----------------------------------|
| **EN ISO 13485:2016/A11:2021**<br>Medical devices - Quality management systems - Requirements for regulatory purposes | V1/2021 | [x] | [ ] |  |
| **EN ISO 14971:2019/A11:2021**<br>Medical devices - Application of risk management to medical devices | V1/2021 | [x] | [ ] |  |
| **EN ISO 23908:2025**<br>Sharps injury protection - Sharps protection mechanisms for single-use needles, introducers for catheters and needles used for blood testing, monitoring, sampling and medical substance administration - Requirements and test methods (ISO 23908:2024) | V1/2025 | [x] | [ ] |  |
| **IEC 62366-1:2015/AMD1:2020**<br>Amendment 1 - Medical devices - Part 1: Application of usability engineering to medical devices | V1/2020 | [x] | [ ] |  |
| **EN ISO 11608-1:2022**<br>Needle-based injection systems for medical use - Requirements and test methods - Part 1: Needle-based injection systems (ISO 11608-1:2022) | V1/2022 | [x] | [ ] |  |
| **EN ISO 11608-5:2023**<br>Needle-based injection systems for medical use - Requirements and test methods - Part 5: Automated functions (ISO 11608-5:2022) | V1/2023 | [x] | [ ] |  |
| **EN ISO 10993-23:2021/A1:2025**<br>Biological evaluation of medical devices - Part 23: Tests for irritation - Amendment 1: Additional in vitro reconstructed human epidermis models (ISO 10993-23:2021/Amd 1:2025) | V1/2025 | [x] | [ ] |  |
| **EN ISO 10993-5:2009/A11:2025**<br>Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity | V1/2025 | [x] | [ ] |  |
| **EN ISO 10993-10:2023**<br>Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO 10993-10:2021) | V1/2023 | [x] | [ ] |  |
| **EN ISO 10993-1:2020**<br>Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-10) | V1/2020 | [x] | [ ] |  |
| **EN ISO 15223-1:2021**<br>Medical devices - Symbols to be used with information to be supplied by the manufacturer - Part 1: General requirements (ISO 15223-1:2021) | V1/2021 | [x] | [ ] |  |
| **EN ISO 20417:2021**<br>Medical devices - Information to be supplied by the manufacturer | V1/2021 | ☐ | ☐ | |
| **ASTM D4169-23e1**<br>Standard Practice for Performance Testing of Shipping Containers and Systems | V1/2024 | [x] | [ ] |  |
| **ASTM F1980-2021**<br>Standard Guide for Accelerated Aging of Sterile Barrier Systems of Medical Devices | V1/2021 | [x] | [ ] |  |

### A.2 EU Regulations and Directives

| Regulation/Directive | Version/Year | Full Compliance | Partial Compliance | Deviations & Alternative Solutions |
|----------------------|--------------|-----------------|-------------------|-----------------------------------|
| **Regulation (EC) No 1907/2006**<br>REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) | V1/2025 | [x] | [ ] |  |
| **Regulation (EU) 2017/745**<br>Medical Devices Regulation (MDR) | V1/2025 | [x] | [ ] |  |
| **Regulation (EC) No 1272/2008**<br>CLP (Classification, Labelling and Packaging) | V1/2025 | [x] | [ ] |  |
| **Directive 2011/65/EU**<br>RoHS (Restriction of Hazardous Substances) | V1/2025 | [x] | [ ] |  |
| **Commission Delegated Directive (EU) 2015/863**<br>RoHS Amendment - List of restricted substances | V1/2015 | ☐ | ☐ | |
| **Regulation (EU) No 528/2012**<br>Biocidal Products Regulation | V1/2024 | [x] | [ ] |  |
| **Regulation (EU) 2019/1021**<br>Persistent Organic Pollutants (POP) Regulation | V1/2025 | [x] | [ ] |  |
| **Regulation (EU) 2025/40**<br>Packaging and Packaging Waste Regulation | V1/2024 | ☐ | ☐ | |
| **Commission Regulation (EU) No 722/2012**<br>Active implantable medical devices and devices manufactured utilising tissues of animal origin | V1/2012 | [x] | [ ] |  |

---

## Part B: GSPR Compliance Matrix

### B.1 Chapter I - General Requirements

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 1**<br>Devices shall achieve performance intended by manufacturer, suitable for intended purpose, safe and effective, with acceptable risks when weighed against benefits | **Yes** | EN ISO 14971<br>IEC 62366-1<br>EN ISO 10993-1<br>EN ISO 11608-1<br>EN ISO 11608-5<br>EN ISO 23908 | Material Review Report<br>Design verification test report<br>Risk Management Report<br>Instruction For Use<br>Formative Usability Report | According to IEC 62366, formative usability evaluation was conducted to detect and resolve usability flaws in early design stage. Summative evaluation not required as device is similar to RLD. |
| **GSPR 2**<br>Risk reduction means reduction without adversely affecting benefit-risk ratio | **Yes** | EN ISO 14971 | Risk Management Report | |
| **GSPR 3**<br>Manufacturers shall establish, implement, document and maintain risk management system | **Yes** | EN ISO 14971 | Risk Management Plan<br>Risk Management Report | Continuous iterative process throughout device lifecycle |
| **GSPR 3(a)**<br>Establish and document risk management plan for each device | **Yes** | EN ISO 14971 | Risk Management Plan | |
| **GSPR 3(b)**<br>Identify and analyse known and foreseeable hazards | **Yes** | EN ISO 14971 | Risk Management Report | |
| **GSPR 3(c)**<br>Estimate and evaluate risks during intended use and foreseeable misuse | **Yes** | EN ISO 14971 | Risk Management Report | |
| **GSPR 3(d)**<br>Eliminate or control risks in accordance with Section 4 | **Yes** | EN ISO 14971 | Risk Management Report | |
| **GSPR 3(e)**<br>Evaluate impact of production phase and post-market surveillance information | **Yes** | EN ISO 14971 | Risk Management Report | |
| **GSPR 3(f)**<br>Amend control measures if necessary based on evaluation | **Yes** | EN ISO 14971 | Risk Management Report | |
| **GSPR 4**<br>Risk control measures shall conform to safety principles, considering state of the art | **Yes** | EN ISO 14971<br>EN ISO 15223-1<br>EN ISO 20417 | Risk Management Report<br>Instruction For Use<br>Label | Hierarchy: (a) safe design and manufacture, (b) protection measures, (c) information for safety |
| **GSPR 5**<br>Eliminate or reduce risks related to use error | **Yes** | EN ISO 14971<br>EN ISO 15223-1 | Risk Management Report<br>Label | Design for patient safety considering user knowledge and environment |
| **GSPR 6**<br>Characteristics and performance not adversely affected during device lifetime | **Yes** | EN ISO 14971<br>ASTM F1980 | Risk Management Report<br>Stability test report | |
| **GSPR 7**<br>Designed and packaged to maintain performance during transport and storage | **Yes** | EN ISO 14971<br>IEC 62366-1<br>EN ISO 11608-1<br>EN ISO 11608-5<br>EN ISO 23908<br>ASTM D4169 | Risk Management Report<br>Instruction For Use<br>Design verification test report<br>Shipping Test Report | |
| **GSPR 8**<br>All known and foreseeable risks minimised and acceptable when weighed against benefits | **Yes** | EN ISO 14971 | Risk Management Report | |
| **GSPR 9**<br>For Annex XVI devices (products without intended medical purpose) | **No** | | | Not applicable - Simject is a medical device with intended medical purpose (anaphylaxis treatment) |

### B.2 Chapter II - Requirements Regarding Design and Manufacture

#### B.2.1 Chemical, Physical and Biological Properties (GSPR 10)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 10.1**<br>Devices designed to ensure characteristics and performance requirements | **Yes** | EN ISO 14971<br>EN ISO 11608-1<br>EN ISO 11608-5<br>EN ISO 23908<br>EN ISO 10993 series<br>(EC) No 1907/2006<br>REACH, RoHS, CLP, POP regulations | Risk Management Report<br>Design verification test report<br>Biological evaluation plan and assessment report<br>Material Review Report | |
| **GSPR 10.1(a)**<br>Choice of materials and substances (toxicity, flammability) | **Yes** | (EC) No 1907/2006<br>(EU) No 65/2011<br>(EU) 2015/863<br>(EU) No 528/2012<br>(EU) 2019/1021<br>(EU) 2025/40<br>(EC) No 1272/2008 | Material Review Report | Compliance with REACH, RoHS, CLP, POP, and packaging regulations |
| **GSPR 10.1(b)**<br>Compatibility with biological tissues, cells, body fluids | **Yes** | EN ISO 10993-1<br>EN ISO 10993-5<br>EN ISO 10993-10<br>EN ISO 10993-23 | Biological evaluation plan and assessment report | |
| **GSPR 10.1(c)**<br>Compatibility between different implantable parts | **No** | | | Device is not implantable |
| **GSPR 10.1(d)**<br>Impact of processes on material properties | **Yes** | EN ISO 10993 series | Biological evaluation plan and assessment report | |
| **GSPR 10.1(e)**<br>Results of biophysical or modelling research | **Yes** | EN ISO 11608-1<br>EN ISO 11608-5<br>EN ISO 23908 | Technical feasibility analysis | |
| **GSPR 10.1(f)**<br>Mechanical properties (strength, ductility, fracture resistance, etc.) | **Yes** | EN ISO 11608-1<br>EN ISO 11608-5<br>EN ISO 23908 | Model verification report | |
| **GSPR 10.1(g)**<br>Surface properties | **Yes** | EN ISO 10993 series | Biological evaluation plan and assessment report | |
| **GSPR 10.1(h)**<br>Confirmation of chemical and/or physical specifications | **Yes** | EN ISO 10993 series<br>EN ISO 11608 series<br>EN ISO 23908 | Biological evaluation plan and assessment report<br>Material Review Report<br>Design verification test report | |
| **GSPR 10.2**<br>Minimise risk from contaminants and residues | **Yes** | ASTM D4169<br>EN ISO 14971 | Shipping Test Report<br>Risk Management Report | Particular attention to tissues exposed and duration/frequency of exposure |
| **GSPR 10.3**<br>Safe use with materials, substances, gases contacted during use | **Yes** | EN ISO 10993 series | Biological evaluation plan and assessment report | Compatible with medicinal products (epinephrine) |
| **GSPR 10.4.1**<br>Devices containing substances >0.1% w/w shall only contain approved substances | **Yes** | EN ISO 10993 series<br>(EC) No 1907/2006<br>(EC) No 1272/2008 | Biological evaluation plan and assessment report<br>Material Review Report | |
| **GSPR 10.4.2**<br>Justification for presence of CMR and/or endocrine-disrupting substances | **Yes** | (EC) No 1907/2006<br>(EC) No 1272/2008 | Material Review Report | Based on exposure analysis, alternative analysis, functionality argumentation |
| **GSPR 10.4.3**<br>Guidelines on phthalates | **Yes** | EN ISO 14971<br>(EC) No 1907/2006<br>(EU) No 65/2011<br>(EU) 2015/863<br>(EC) No 1272/2008 | Risk Management Report<br>Material Review Report | Benefit-risk assessment of phthalates per guidelines |
| **GSPR 10.4.4**<br>Guidelines on other CMR and endocrine-disrupting substances | **Yes** | (EC) No 1907/2006<br>(EC) No 1272/2008 | Material Review Report | Per relevant scientific committee guidelines |
| **GSPR 10.4.5**<br>Labelling of CMR/endocrine-disrupting substances | **Yes** | EN ISO 15223-1<br>EN ISO 20417 | Label | Substances >0.1% w/w labelled on device/packaging; residual risks in IFU |
| **GSPR 10.5**<br>Reduce risks from unintentional ingress of substances | **Yes** | EN ISO 14971<br>EN ISO 11608 series<br>EN ISO 23908 | Risk Management Report<br>Design verification test report | |
| **GSPR 10.6**<br>Reduce risks linked to size and properties of particles released | **Yes** | EN ISO 14971<br>EN ISO 11608 series<br>EN ISO 23908 | Risk Management Report<br>Design verification test report | Special attention to nanomaterials |

#### B.2.2 Infection and Microbial Contamination (GSPR 11)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 11.1**<br>Design to eliminate or reduce risk of infection | **Yes** | EN ISO 14971<br>EN ISO 11608 series<br>EN ISO 23908 | Risk Management Report<br>Design verification test report | Reduces risks from cuts/pricks, ensures safe handling, prevents microbial contamination |
| **GSPR 11.2**<br>Designed to facilitate safe cleaning, disinfection, and/or re-sterilisation | **No** | | | Disposable product - does not require disinfection and sterilization |
| **GSPR 11.3**<br>Devices labelled with specific microbial state | **No** | | | Disposable product - non-sterile product |
| **GSPR 11.4**<br>Devices delivered in sterile state | **No** | | | Disposable product - non-sterile product |
| **GSPR 11.5**<br>Devices labelled as sterile | **No** | | | Disposable product - non-sterile product |
| **GSPR 11.6**<br>Devices intended to be sterilised | **No** | | | Disposable product - non-sterile product |
| **GSPR 11.7**<br>Packaging systems for non-sterile devices | **Yes** | EN ISO 15223-1<br>EN ISO 20417 | Label | Maintains integrity and cleanliness |
| **GSPR 11.8**<br>Labelling to distinguish sterile vs non-sterile devices | **No** | | | Disposable product - non-sterile product |

#### B.2.3 Medicinal Product Substances (GSPR 12)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 12.1**<br>Devices incorporating substances considered to be medicinal products | **No** | | | Combination product of medicinal product + medical device; medicinal product (epinephrine) is dominant component. Safety and effectiveness depend primarily on drug quality and dosage accuracy. |
| **GSPR 12.2**<br>Devices composed of substances absorbed by or locally dispersed in human body | **No** | | | Same justification as GSPR 12.1 |

#### B.2.4 Materials of Biological Origin (GSPR 13)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 13.1**<br>Devices manufactured using derivatives of tissues or cells of human origin | **No** | | | Device is of non-biological origin |
| **GSPR 13.2**<br>Devices manufactured using tissues or cells of animal origin | **No** | | | Device is of non-biological origin |
| **GSPR 13.3**<br>Devices manufactured using non-viable biological substances | **No** | | | Device is of non-biological origin |

#### B.2.5 Construction and Environment Interaction (GSPR 14)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 14.1**<br>Use in combination with other devices/equipment | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>IEC 62366-1 | Label<br>Formative Usability Report | Safe combination, minimises misconnection risks |
| **GSPR 14.2(a)**<br>Risks of injury from physical features (volume/pressure, dimensional, ergonomic) | **Yes** | EN ISO 14971<br>EN ISO 11608 series<br>EN ISO 23908 | Risk Management Report<br>Design verification test report | |
| **GSPR 14.2(b)**<br>Risks from external influences/environmental conditions | **Yes** | EN ISO 14971<br>EN ISO 11608 series<br>EN ISO 23908 | Risk Management Report<br>Design verification test report | Magnetic fields, EMI, electrostatic discharge, radiation, pressure, humidity, temperature |
| **GSPR 14.2(c)**<br>Risks from contact with materials, liquids, substances during use | **Yes** | EN ISO 14971<br>EN ISO 11608 series<br>EN ISO 23908 | Risk Management Report<br>Design verification test report | |
| **GSPR 14.2(d)**<br>Risks from software and IT environment interaction | **Yes** | EN ISO 14971<br>EN ISO 11608 series<br>EN ISO 23908 | Risk Management Report<br>Design verification test report | |
| **GSPR 14.2(e)**<br>Risks of accidental ingress of substances | **Yes** | EN ISO 14971<br>EN ISO 11608 series<br>EN ISO 23908 | Risk Management Report<br>Design verification test report | |
| **GSPR 14.2(f)**<br>Risks of reciprocal interference with other devices | **Yes** | EN ISO 14971<br>EN ISO 11608 series<br>EN ISO 23908 | Risk Management Report<br>Design verification test report | |
| **GSPR 14.2(g)**<br>Risks from ageing, loss of accuracy when maintenance not possible | **Yes** | EN ISO 14971<br>EN ISO 11608 series<br>EN ISO 23908 | Risk Management Report<br>Design verification test report | |
| **GSPR 14.3**<br>Risks of fire or explosion | **Yes** | EN ISO 14971<br>EN ISO 15223-1<br>EN ISO 20417 | Risk Management Report<br>Label | |
| **GSPR 14.4**<br>Safe adjustment, calibration, and maintenance | **Yes** | EN ISO 11608 series<br>EN ISO 23908 | Design verification test report | |
| **GSPR 14.5**<br>Reliable and safe interoperability and compatibility | **No** | | | Device does not connect to other devices |
| **GSPR 14.6**<br>Measurement, monitoring, display scale design | **Yes** | EN ISO 11608 series<br>EN ISO 23908 | Design verification test report | Ergonomic principles, intended purpose, users, environmental conditions |
| **GSPR 14.7**<br>Safe disposal of device and waste | **Yes** | EN ISO 15223-1<br>EN ISO 20417 | Label | Procedures described in IFU |

#### B.2.6 Diagnostic or Measuring Function (GSPR 15)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 15.1**<br>Sufficient accuracy, precision, and stability for diagnostic/measuring function | **No** | | | Product does not have diagnostic or measurement function |
| **GSPR 15.2**<br>Measurements expressed in legal units | **No** | | | Product does not have measurement function |

#### B.2.7 Protection Against Radiation (GSPR 16)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 16.1-16.4**<br>Protection against radiation (general, intended, unintended, ionizing) | **No** | | | Device is non-radiation device |

#### B.2.8 Electronic Programmable Systems (GSPR 17)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 17.1-17.4**<br>Devices incorporating electronic programmable systems and software | **No** | | | Device is non-electronic programmable system; no software as medical device |

#### B.2.9 Active Devices (GSPR 18)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 18.1-18.8**<br>Active devices and devices connected to them | **No** | | | Device is non-active device; does not connect to other devices |

#### B.2.10 Active Implantable Devices (GSPR 19)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 19.1-19.4**<br>Particular requirements for active implantable devices | **No** | | | Device is non-active implantable device |

#### B.2.11 Mechanical and Thermal Risks (GSPR 20)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 20.1**<br>Protection against mechanical risks | **Yes** | EN ISO 14971<br>EN ISO 11608-1 | Risk Management Report<br>Design verification test report | Movement resistance, instability, moving parts |
| **GSPR 20.2**<br>Risks from vibration | **No** | | | Device is non-vibration |
| **GSPR 20.3**<br>Risks from noise emitted | **Yes** | EN ISO 14971 | Risk Management Report | |
| **GSPR 20.4**<br>Terminals and connectors to energy supplies | **No** | | | Device does not connect to other devices |
| **GSPR 20.5**<br>Errors fitting/refitting parts that could be source of risk | **Yes** | EN ISO 14971<br>EN ISO 15223-1<br>EN ISO 20417 | Risk Management Report<br>Instruction For Use<br>Label | |
| **GSPR 20.6**<br>Dangerous temperatures of accessible parts | **No** | | | Device will not generate heat during use |

#### B.2.12 Energy or Substances Supply (GSPR 21)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 21.1**<br>Accurate delivery of energy or substances | **Yes** | EN ISO 11608-1<br>EN ISO 11608-5<br>EN ISO 23908 | Design verification test report | |
| **GSPR 21.2**<br>Prevent/indicate inadequacies in energy/substances delivered | **Yes** | EN ISO 11608-1<br>EN ISO 11608-5<br>EN ISO 23908 | Design verification test report | Prevent accidental release of dangerous levels |
| **GSPR 21.3**<br>Clearly specified controls and indicators | **Yes** | EN ISO 11608 series<br>EN ISO 23908<br>EN ISO 15223-1<br>EN ISO 20417 | Design verification test report<br>Label | |

#### B.2.13 Lay Person Use (GSPR 22)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 22.1**<br>Devices for use by lay persons - appropriate performance | **Yes** | EN ISO 11608 series<br>EN ISO 23908<br>EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 14971 | Design verification test report<br>Label<br>Risk Management Report | Considering lay person skills and means; easy to understand information |
| **GSPR 22.2**<br>Safe and accurate use by lay person; reduce needle stick injuries | **Yes** | EN ISO 11608 series<br>EN ISO 23908<br>EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 14971 | Design verification test report<br>Label<br>Risk Management Report | |
| **GSPR 22.3**<br>Verification procedure for lay person | **Yes** | EN ISO 11608 series<br>EN ISO 23908<br>EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 14971 | Design verification test report<br>Label<br>Risk Management Report | Verify device will perform as intended; warn if failed |

### B.3 Chapter III - Requirements Regarding Information Supplied With Device (GSPR 23)

| GSPR Requirement | Applies? | Standards Applied | Evidence of Conformance | Justification/Comments |
|------------------|----------|-------------------|-------------------------|------------------------|
| **GSPR 23.1**<br>General requirements for information supplied by manufacturer | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | Medium, format, content, legibility appropriate to intended user |
| **GSPR 23.1(a)**<br>Appropriate medium, format, content, legibility, location | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | Readily understood by intended user; supplemented with drawings/diagrams |
| **GSPR 23.1(b)**<br>Information on label (device itself or packaging) | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.1(c)**<br>Human-readable labels; may be supplemented by machine-readable (RFID, barcodes) | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.1(d)**<br>Instructions for use provided together with devices | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | Exception for Class I/IIa devices not applicable |
| **GSPR 23.1(e)**<br>Single copy of IFU for multiple devices to single user | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.1(f)**<br>Non-paper format IFU (electronic) | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | Per Regulation (EU) No 207/2012 |
| **GSPR 23.1(g)**<br>Residual risks as limitations, contra-indications, precautions, warnings | **Yes** | EN ISO 11608-1 | Instruction For Use | |
| **GSPR 23.1(h)**<br>Internationally recognised symbols; identification colours | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.2**<br>Information on the label | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.2(a)**<br>Name or trade name of the device | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | **Yes** - Included |
| **GSPR 23.2(b)**<br>Details to identify device, packaging contents, intended purpose | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.2(c)**<br>Name, trade name, trademark of manufacturer; registered address | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.2(d)**<br>Authorised representative (if manufacturer outside EU) | **No** | | | Not applicable for device in integral product |
| **GSPR 23.2(e)**<br>Indication if device contains medicinal substance or tissues/cells of human/animal origin | **No** | | | Not applicable |
| **GSPR 23.2(f)**<br>Information labelled per Section 10.4.5 | **Yes** | EN ISO 15223-1<br>EN ISO 20417 | Label | |
| **GSPR 23.2(g)**<br>Lot number or serial number | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.2(h)**<br>UDI carrier | **No** | | | Not applicable for device in integral product |
| **GSPR 23.2(i)**<br>Time limit for safe use (year/month) | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.2(j)**<br>Date of manufacture if no time limit | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.2(k)**<br>Special storage and/or handling conditions | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.2(l)**<br>Sterile state and sterilisation method | **No** | | | Not applicable (non-sterile) |
| **GSPR 23.2(m)**<br>Warnings or precautions needing immediate attention | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.2(n)**<br>Single use indication | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.2(o)**<br>Reprocessed single-use device indication | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.2(p)**<br>Custom-made device indication | **No** | | | Not applicable |
| **GSPR 23.2(q)**<br>Indication that device is a medical device | **No** | | | Not applicable |
| **GSPR 23.2(r)**<br>Qualitative and quantitative composition for substances introduced into body | **No** | | | Not applicable |
| **GSPR 23.2(s)**<br>Serial number for implantable devices | **No** | | | Not applicable (non-active implantable device) |
| **GSPR 23.3**<br>Information on sterile packaging | **No** | | | Non-sterile device - entire section not applicable |
| **GSPR 23.4**<br>Information in the instructions for use | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(a)**<br>Particulars from Section 23.2 (a, c, e, f, k, l, n, r) | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(b)**<br>Intended purpose; indications, contra-indications, target patient group, intended users | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(c)**<br>Specification of clinical benefits | **No** | | | Not applicable for device in integral product |
| **GSPR 23.4(d)**<br>Links to summary of safety and clinical performance (SSCP) | **No** | | | Not applicable for device in integral product |
| **GSPR 23.4(e)**<br>Performance characteristics | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(f)**<br>Information for healthcare professional to verify suitability and select software/accessories | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(g)**<br>Residual risks, contra-indications, undesirable side-effects | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(h)**<br>Specifications required for appropriate use (e.g., accuracy) | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(i)**<br>Preparatory treatment or handling before/during use | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(j)**<br>Special facilities, training, or qualifications required | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(k)**<br>Information to verify proper installation and readiness | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | Maintenance, calibration, consumables, risk elimination methods |
| **GSPR 23.4(l)**<br>Instructions if sterile packaging damaged | **No** | | | Non-sterile device |
| **GSPR 23.4(m)**<br>Instructions for sterilisation before use (non-sterile device) | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(n)**<br>Information on reuse processes (reusable devices) | **No** | | | Non-reusable device |
| **GSPR 23.4(o)**<br>Indication that device can be reused only if reconditioned by manufacturer | **No** | | | Disposable device - not applicable |
| **GSPR 23.4(p)**<br>Information on characteristics/technical factors posing risk if re-used | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | Based on risk management documentation |
| **GSPR 23.4(q)**<br>Information for use with other devices/equipment | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | Identification and restrictions for combinations |
| **GSPR 23.4(r)**<br>Information for devices emitting radiation | **No** | | | Non-radiation device - not applicable |
| **GSPR 23.4(s)**<br>Warnings, precautions, contra-indications, measures, limitations | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | Malfunction, environmental influences, interference, substance limitations |
| **GSPR 23.4(t)**<br>Warnings for devices composed of absorbed/dispersed substances | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | Metabolism interaction, contra-indications, side-effects, overdose risks |
| **GSPR 23.4(u)**<br>Qualitative and quantitative information on materials for implantable devices | **No** | | | Non-implantable device |
| **GSPR 23.4(v)**<br>Warnings/precautions for safe disposal | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | Infection/microbial hazards, physical hazards (sharps) |
| **GSPR 23.4(w)**<br>Circumstances when lay user should consult healthcare professional | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(x)**<br>Information on absence of clinical benefit and risks | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | For Article 1(2) devices |
| **GSPR 23.4(y)**<br>Date of issue of IFU (or latest revision) | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(z)**<br>Notice to report serious incidents to manufacturer and competent authority | **Yes** | EN ISO 15223-1<br>EN ISO 20417<br>EN ISO 11608-1 | Label<br>Instruction For Use | |
| **GSPR 23.4(aa)**<br>Information supplied to patient with implanted device | **No** | | | Non-implantable device |
| **GSPR 23.4(ab)**<br>Hardware, IT network, IT security requirements for electronic programmable systems | **No** | | | Device doesn't incorporate electronic programmable systems |

---

## Document Control

| Field | Information |
|-------|-------------|
| **Document Date** | 12 November 2025 |
| **Regulatory Reference** | MDR Annex XV, Section 2.7 (Chapter II of Annex XV) |
| **Applicable Regulation** | Regulation (EU) 2017/745 (Medical Devices Regulation) |
| **Device Classification** | Combination product (medicinal product + medical device) |
| **Device Status** | Component of final combination product (not standalone medical device) |

---

## Notes

1. **Regulatory Framework**: This checklist is prepared according to Section 2.7 of Chapter II of Annex XV of Regulation (EU) 2017/745 (MDR).

2. **Combination Product Status**: The Simject Auto-Injector is classified as a combination product of medicinal product (epinephrine) and medical device. The medicinal product is the dominant component.

3. **Evidence Documents**: Referenced documents include:
   - Risk Management Report
   - Design Verification Test Reports
   - Biological Evaluation Plan and Assessment Report
   - Material Review Report
   - Instruction For Use (IFU)
   - Formative Usability Report
   - Label (Primary and Secondary Packaging)
   - Shipping Test Report
   - Stability Test Report

4. **Standards Version**: All standards referenced are the latest applicable versions as of document date.

5. **Non-Applicability**: Requirements marked as "No" in the "Applies?" column are justified based on device characteristics (non-sterile, disposable, non-implantable, non-active, non-electronic, non-radiation, non-biological origin).

---

**Document End**
